Search Results for: stem cell biotech

Weekly reads: Bezos & stem cells for anti-aging, Myc, more

young blood, stem cells anti-aging

Stem cells may have anti-aging properties, but they are unlikely to be a real fountain of youth. Even so, people are obsessed with aging and stem cells regularly are thought of as “the ticket” for fighting aging. I’ll start today’s recommended reads with that topic and then go on to list some interesting papers of […]

Weekly reads: Bezos & stem cells for anti-aging, Myc, more Read More »

Congrats to Lusubilo Mwalilino, the winner of our stem cell video contest

Lusubilo Mwalilino, the winner of our stem cell video contest

Every year I run a number of contests here on The Niche and the most recent is a stem cell video contest.   I’m pleased to announce the winner of our contest is Lusubilo Mwalilino. You can see her video entry above, which is now part of our stem cell YouTube channel. Please check out

Congrats to Lusubilo Mwalilino, the winner of our stem cell video contest Read More »

FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it

cryo cell infusion clinic marketing

I recently found concerning SEC filings from the biotech Cryo-Cell about a deal it has with a Duke team for infusions of children with unproven umbilical cord cells. This turns out to be a $58 million deal. It relates in a major way to a Duke compassionate use or expanded access program (EAP) that already had raised

FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it Read More »

Review of Bioinformant, unproven stem cell clinic promotion, NIH & Pfizer as clients?

Bioinformant stem cell t-shirt

A few years ago a promotional website called Bioinformant popped up in the stem cell arena. It’s very different in some ways than most other stem cell-related websites that I’ve seen. It’s a marketing and promotion site. What’s the backstory? I believe there’s reason for concern here specifically related to Bioinformant promoting unproven stem cell

Review of Bioinformant, unproven stem cell clinic promotion, NIH & Pfizer as clients? Read More »

Stem cell therapy for diabetes updates: expected IPO, CRISPR, new pubs, more

stem cell therapy for diabetes

The idea of stem cell therapy for diabetes is both exciting and in a way practical. By that I mean that there’s a good common sense foundation here. The idea of stem cell therapy for diabetes What do I mean? If medical researchers can replace lost beta cells in the pancreas using stem cell-produced beta

Stem cell therapy for diabetes updates: expected IPO, CRISPR, new pubs, more Read More »

Weekly reads & stem cell news: New York axes NYSTEM, fetal tissue rules reversed, pubs & more

stem cell book

It’s been a week with a wide variety of regenerative medicine papers and stem cell news. Here’s my earlier take from a few days ago on the Belmonte-led human-monkey chimeric embryo paper in Cell that broke this week. A few days ago I also put up a new video on our Stem Cell YouTube Channel

Weekly reads & stem cell news: New York axes NYSTEM, fetal tissue rules reversed, pubs & more Read More »

Weekly stem cell research reads: BAF, Polycomb, Fertility, More

jonathan hoggatt, Moderna, stem cell research

What might be most surprising about this week’s recommended stem cell research reads is there’s nothing about COVID-19 in here. There are, however, some really great papers. And we can expect more developments on the cellular medicine for COVID-19 front coming soon. Before I jump into the reads, if you haven’t already check out our

Weekly stem cell research reads: BAF, Polycomb, Fertility, More Read More »